首页|基于网络药理学探讨赤芍抗肿瘤转移的作用机制

基于网络药理学探讨赤芍抗肿瘤转移的作用机制

扫码查看
目的 通过网络药理学的方法探究赤芍抗肿瘤转移的作用机制。方法 通过中药系统药理学数据库与分析平台(TCMSP)和PharmMapper数据库获取赤芍的活性成分及靶点,通过GeneCards和在线人类孟德尔遗传(OMIM)数据库中获得肿瘤转移的相关靶点,进而获得药物活性成分治疗疾病的潜在靶点。构建蛋白质互作(PPI)网络,用DAVID数据库对潜在靶点进行富集分析,并利用CytoScape 3。9。0软件对核心成分和关键靶点进行筛选,同时进行分子对接验证。结果 共得到符合条件的药物活性成分29个及其作用靶点132个、交集靶点115个。主要信号通路有癌症信号通路、脂质和动脉粥样硬化、前列腺癌等。分子对接结果表明赤芍抗肿瘤转移的核心成分与疾病的核心靶点有较强的结合活性。结论 赤芍通过多成分、多靶点、多途径发挥抗肿瘤转移作用。
Exploration of the mechanism of action of Radix Paeoniae Rubra for anti-tumor metastasis based on network pharmacology
Objective To explore the mechanism of action of Radix Paeoniae Rubra for anti-tumor metastasis through network pharmacology.Methods The active ingredients and targets of Radix Paeoniae Rubra were obtained through traditional Chinese medicine systems pharmacology database and analysis platform(TCMSP)and PharmaMapper databases,and tumor metastasis-related targets were obtained through GeneCards and online mendelian inheritance in man(OMIM)databases,thereby obtaining potential targets for drug active ingredients to treat diseases.A protein-protein interaction(PPI)network was built,enrichment analysis of potential targets was conducted using the DAVID database,and core components and key targets were screened using Cytoscape 3.9.0 software while conducting molecular docking verification.Results A total of 29 eligible drug active ingredients,and their 132 action targets and 115 intersection targets were obtained.The main signal pathways included cancer signal pathway,lipids and atherosclerosis,prostate cancer,etc.The molecular docking results indicated that the core components of Radix Paeoniae Rubra in anti-tumor metastasis had a strong binding activity with the core targets of diseases.Conclusion Radix Paeoniae Rubra exerts anti-tumor metastasis effects through multiple components,targets,and pathways.

Network pharmacologyRadix Paeoniae RubraTumor metastasisMechanism of action

费庆林、罗琴、张阳、韩立

展开 >

南阳理工学院张仲景国医国药学院 河南省张仲景方药与免疫调节重点实验室,河南南阳 473004

网络药理学 赤芍 肿瘤转移 作用机制

国家自然科学基金面上项目河南省科技发展计划项目

82074076202300410022

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(1)
  • 25